Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

727
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
727
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Amines to Sulfonamides: The Hinsberg Test01:23

Amines to Sulfonamides: The Hinsberg Test

3.5K
The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing...
3.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

568
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
568
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

241
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
241
Electrophilic Aromatic Substitution: Sulfonation of Benzene01:22

Electrophilic Aromatic Substitution: Sulfonation of Benzene

6.1K
Sulfonation of benzene is a reaction wherein benzene is treated with fuming sulfuric acid at room temperature to produce benzenesulfonic acid. Fuming sulfuric acid is a mixture of sulfur trioxide and concentrated sulfuric acid.
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SHIP1 is required for T cell surveillance of occult malignancies.

Cellular and molecular life sciences : CMLS·2026
Same author

Relationship Between Food Security and Walking for Transportation: Findings by Region and Rurality.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2026
Same author

Orthographic Knowledge as a Predictor of Writing Composition in European Portuguese: A Longitudinal Study in Grade 2.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Public Policy to Support the Health of Caregivers in the Workforce.

American journal of health promotion : AJHP·2026
Same author

HIV-1 late diagnosis: Strategies to overcome the misclassification of individuals acutely infected with HIV-1 as individuals diagnosed late.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Rural Active Living: A Call to Action 2.0, 10-Year Review and Recommendations to Advance the Field.

Journal of public health management and practice : JPHMP·2026

Related Experiment Video

Updated: Jul 7, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K

Structure-Activity Studies on Bis-Sulfonamide SHIP1 Activators.

Shea T Meyer1, Sandra Fernandes2, Robert E Anderson1

  • 1Department of Chemistry, Syracuse University, Syracuse, NY 13244, USA.

Molecules (Basel, Switzerland)
|December 23, 2023
PubMed
Summary
This summary is machine-generated.

Small molecules that activate the SHIP1 enzyme show promise for treating inflammatory disorders and Alzheimer's disease. New analogs demonstrate improved potency and stability, offering potential therapeutic benefits.

Keywords:
SHIP1SHIP2activatorphosphatasesulfonamide

More Related Videos

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

10.1K
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

9.7K

Related Experiment Videos

Last Updated: Jul 7, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K
NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

10.1K
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

9.7K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neuroscience

Background:

  • SH2-containing inositol polyphosphate 5-phosphatase 1 (SHIP1) antagonizes PI3K activity, implicating it in inflammatory conditions.
  • SHIP1's role in promoting microglial phagolysosomal lipid degradation suggests therapeutic potential for Alzheimer's disease.

Purpose of the Study:

  • To discover and develop small molecules that enhance SHIP1 enzymatic activity.
  • To establish structure-activity relationships for SHIP1 activators.
  • To improve the in vivo stability and potency of SHIP1-activating compounds.

Main Methods:

  • Synthesis and evaluation of a series of bis-sulfonamide analogs.
  • Structure-activity relationship studies to optimize compound design.
  • Assessment of compound potency and oxidative degradation profiles.

Main Results:

  • Identification of novel SHIP1 activators with enhanced potency.
  • Demonstration that thiophene and thiomorpholine moieties can be replaced with alternative groups.
  • Development of SHIP1 activators with reduced susceptibility to oxidative degradation.

Conclusions:

  • Small molecule activators of SHIP1 represent a promising therapeutic strategy for inflammatory disorders and Alzheimer's disease.
  • Chemical modifications can improve the potency and pharmacokinetic properties of SHIP1 activators.
  • The development of stable SHIP1 activators offers a viable approach for drug discovery in neurodegenerative and inflammatory diseases.